复杂性青光眼的减压阀植入术疗效观察  

Clinical effect of glaucoma valve implantation for clinical challenging refractory glaucoma

作　　者：盛晓捷 徐丽[1] 王海瑛[1] 刘驰[1] 朱洪丽[1] 孙燕[1] 范淑环 

机构地区：[1]中国辽宁省沈阳市第四人民医院眼科,110031

出　　处：《国际眼科杂志》2006年第4期813-815,共3页International Eye Science

摘　　要：目的:为探讨后房型及玻璃体腔型减压阀植入联合玻璃体手术治疗临床复杂的难治性青光眼的临床疗效,进行了进一步的探索与实践。方法:选择住院的各种难治性青光眼患者共31例(31眼),后房组16例,玻璃体腔组联合玻璃体切除15例。结果:术后随访6～12(平均8.6)mo。术后眼压控制在8～20mmHg(1mmHg=0.133kPa)之间者28眼(90%),其中完全成功23眼(74%),贝他根眼药水点眼条件成功5眼(16%),手术失败3眼(10%)。术前平均眼压47.33±12.45mmHg,术后末次随访时平均眼压12.83±7.54mmHg,比术前眼压降低75%。术前术后眼压经t检验,P<0.01,差异有显著性。患者术后视力改善者8眼,其中1眼矫正视力达0.4;视力不变者20眼。结论:后房型或玻璃体腔型减压阀植入联合玻璃体手术治疗临床复杂的难治性青光眼,眼压控制效果良好,并发症少,值得推广应用。AIM： To analyze the clinical effect and complications of Ahmed glaucoma valve multipathway compound implantation to further investigations for clinically challenging refractory glaucoma. METHODS： A retrospective review was conducted on the charts of 31eyes of 31 patients with refractory glaucoma treated with Ahmed glaucoma valve implant placement via posterior chamber （16 eyes） and ciliarotomy combined vitrectomy （ 15 eyes）. RESULTS： The mean postoperative intraocular pressure （IOP） （12.80± 7.54mmHg） was significantly lower than the mean preoperative IOP （47.30± 12.45mmHg） at last follow up （mean 8.6 months; range 6-12 months） （P〈0.01, t-test）. Overall, there were 23 eyes （74%） classified as complete successes, 5 eyes （16%） qualified successes, and 3 eyes failed （10%）. Eight eyes had improvement of visual acuity, in which 1 eye imported to 0.4. Twenty eyes had maintained of visual acuity. CONCLUSION： Ahmed glaucoma valve multipathway implantation is an effective and relatively safe therapy for the treatment of refractory glaucoma, and provide good control of IOP with low incidence of complications.

关 键 词：Ahmed减压阀 多途径 复杂性青光眼 

分 类 号：R779.6[医药卫生—眼科]